Variable at baseline visit | All participants NÂ =Â 403 |
---|---|
Age (years), median (IQR) | 43 (39, 49) |
Sex (N, % women) | 78 (19) |
Race/ethnicity by self-report (N, %) | |
 Non-Hispanic Black | 174 (43.2) |
 Non-Hispanic White | 178 (44.2) |
 Hispanic | 42 (10.4) |
 Other | 9 (2.2) |
Estimated duration of HIV infection (months), median (IQR) | 118 (57, 183) |
Nadir CD4+ T-cell count, median (IQR) | 180 (56, 315) |
AIDS status (N, %) | 245 (61) |
Virus detectability in plasma (N, %Â >LLQ) | 215 (54) |
Virus detectability in CSF (N, Â %Â >LLQ) | 126 (31)a |
CSF VL (log10 HIV RNA copies/mL), median (IQR) | 1.7 (1.7, 2.2)a |
ZDV use (N, % yes) | 79 (20) |
Comorbidity (% mild to moderate) | 134 (33) |
Current alcohol abuse (N, % yes) | 10 (2.5) |
Hemoglobin, mean ± SD | 14.1 ± 1.5 |
Anemia (N, Â %) | 54 (14) |
CSF iron (µg/dL), median (IQR)b | 3.1 (1.6, 5.7) |
CSF transferrin (µg/mL), median (IQR)b | 17.2 (10.3, 27.6) |
CSF ferritin (ng/mL), median (IQR)b | 2.7 (1.4, 4.2) |